Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;27(13):22-00254.
doi: 10.2807/1560-7917.ES.2022.27.13.2200254.

Letter to the editor: Epidemiology of the SARS-CoV-2 variant Omicron BA.2 - vigilance needed

Affiliations

Letter to the editor: Epidemiology of the SARS-CoV-2 variant Omicron BA.2 - vigilance needed

Jing Huang et al. Euro Surveill. 2022 Mar.
No abstract available

Keywords: BA.1; BA.2; COVID-19; Omicron; SARS-CoV-2; variant of concern.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare no competing interests.

References

    1. Fonager J, Bennedbæk M, Bager P, Wohlfahrt J, Ellegaard KM, Ingham AC, et al. Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022. Euro Surveill. 2022;27(10)2200181. 10.2807/1560-7917.ES.2022.27.10.2200181 - DOI - PMC - PubMed
    1. Yamasoba D, Kimura I, Nasser H, Morioka Y, Nao N, Ito J, et al. Virological characteristics of SARS-CoV-2 BA.2 variant. bioRxiv. 2022:2022.02.14.480335. Preprint. 10.1101/2022.02.14.480335 - DOI
    1. Takashita E, Kinoshita N, Yamayoshi S, Sakai-Tagawa Y, Fujisaki S, Ito M, et al. Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2. N Engl J Med.2022;386(10):995-8. 10.1056/NEJMc2119407 - DOI - PMC - PubMed
    1. Iketani S, Liu L, Guo Y, Liu L, Chan JF, Huang Y, et al. Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature. 2022. . Epub ahead of print.10.1038/s41586-022-04594-4 - DOI - PMC - PubMed
    1. Chen J, Wei GW. Omicron BA.2 (B.1.1.529.2): high potential to becoming the next dominating variant. Res Sq. 2022:23:rs.3.rs-1362445. Preprint.

Supplementary concepts